Innoviva Inc. Reports Second Quarter 2016 Financial Results
BRISBANE, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ:INVA) today reported financial results for the second quarter ended June 30, 2016. Royalties earned on net sales of RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA® from Glaxo Group Limited (GSK) during the second quarter of 2016 were $35.7 million, up from $13.9 million in the second quarter of 2015.